Marathon Petroleum Corporation AI Price Prediction

The stock has sold off sharply in the last month, down 14.0%, pushing the RSI to an extremely oversold level of 16.75. However, the price remains above the 200-day moving average at $145.50, indicating the longer-term trend is still intact even as the near-term momentum is negative. This setup suggests elevated short-term downside risk but a potentially favorable entry point for longer-term investors.

• A 14.0% decline in the last month signals strong negative short-term momentum and likely risk-off sentiment toward the name or the sector.
• RSI at 16.75 is deeply oversold (well below the typical 30 threshold), often associated with capitulation or at least a near-term exhaustion of selling pressure.
• Current price of $162.93 remains above the 200-day moving average of $145.50, implying the broader trend is still upward despite the recent correction.

Alternative data for Marathon Petroleum is mixed but not strongly directional. Web traffic is flat, suggesting stable customer or stakeholder interest, while social media presence is growing modestly on key platforms, particularly Facebook. The notable negative is a 23.4% month-over-month decline in job openings, which may reflect either efficiency gains or caution on growth and capital spending.

• Website traffic at ~70,394 visitors per month with 0.0% month-over-month growth indicates stable but not expanding digital engagement.
• Job openings at 304, down 23.4% month over month, could signal hiring restraint, potential cost control, or slower anticipated growth.
• Social media metrics show modest growth (e.g., Facebook followers up 7.4% over 90 days, small gains on Instagram and YouTube, flat on Twitter/X), pointing to steady but not explosive brand engagement; LinkedIn following is large (358,444), consistent with a significant corporate footprint.

Overall, Marathon Petroleum’s fundamentals and valuation appear supportive, but the stock is undergoing a sharp short-term correction. Extremely oversold technicals suggest potential for a rebound, yet the recent price weakness and softer hiring trends temper an outright bullish stance. The balance of evidence points to a neutral view with a constructive bias for investors with a longer time horizon.

• Strong earnings and a low PE multiple are supportive of the equity story, but the market is currently discounting the stock amid a 14.0% monthly drawdown.
• Technical and alternative data together indicate short-term caution but no clear sign of structural deterioration, suggesting the risk/reward may be improving for patient investors.